Anemia Flashcards

1
Q

MCV < 80 fL

A

microcytic
-due to iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MCV 80-100 fL

A

normocytic
-cause: acute blood loss, malignancy, CKD, bone marrow, hemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MCV > 100 fL

A

macrocytic
-likely due to vitamin B12 or folate deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dx of iron deficiency anemia

A
  • decrease Hgb, low MCV, RBC production
    -decrease serum iron, ferritin and TSAT
  • increase TIBC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

iron deficiency anemia tx

A

-100-200 mg elemental iron/day
-take on empty stomach
-avoid H2RAs and PPI - separate from antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ferrous sulfate

A

20% elemental iron
-325 mg (65 mg of elemental iron) PO TID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ferrous sulfate dried

A

30% elemental iron
-160 mg (50 mg elemental iron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

safety of oral iron

A

-accidental overdose of iron-containing products in children that can cause fatal poisoning under 6
-constipation, dark and tarry stools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

iron overdose antidote

A

deferoxamine (desferal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

antacids, H2RAs and PPIs

A

decrease iron absorption by increasing gastric PH
-take 2 hours before or 4 hours after taking antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

quinolone and tetracycline abx & iron

A

take iron two hours before or 4-8 hrs after these agents due to chelation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

bisphosphonates & iron

A

take iron 60 min after oral ibandronate or 30 minutes after alendronate/risedronate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

levothyroxine and iron

A

separate from iron by 2-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

vitamin C

A

increases the absorption of iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when to use IV iron

A

CKD on HD
CKD on ESAs
unable to tolerate oral iron or failure of oral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

iron sucrose (venofer) and ferumoxytol (feraheme)

A

-serious and sometimes fatal anaphylactic reactions iron dextran or ferumoxytol; all patients receiving iron dextran should be given a test dose
-all parenteral iron products carry a risk for hypersensitivity reactions

17
Q

causes of macrocytic anemia

A

vitamin B12, folate deficiency, alcoholism, poor nutrition, GI disorders, and pregnancy

18
Q

dx of macrocytic anemia

A

-low hgb and high MCV
-low B12 or folate

19
Q

tx of macrocytic anemia

A

-vitamin B12 injections (cyanocobalmin) are first line - IM or deep SC 100-1000 mcg daily/weekly/monthly
-Folic acid, folate

20
Q

Anemia of chronic kidney disease

A

deficiency in EPO

21
Q

tx of anemia of CKD

A

IV iron is first line for HD patients (non-HD can have oral iron

22
Q

ESAs

A

Epoetin Alfa (Epogen, Procrit)
Darbepoetin (Aranesp)

*help maintain Hgb levels and reduce the need for blood transfusions but are ineffective if iron stores are low

23
Q

Epogen, Procrit

A

CKD:
-3x/week
-initiate when Hgb < 10 g/dL
-decrease or interrupt dose when Hgb approaches or exceeds 11 g/dL
Cancer:
-initiate when Hgb < 10 g/dL

24
Q

Aranesp

A

CKD:
-IV or SC weekly
-half-life is 3 fold longer than epogen

25
Q

all ESAs

A

-increase risk of death, MI, stroke, VTE, thrombosis
-use lowest effective dose
-CKD: increase risk of death when hgb > 11 g/dL
-cancer: no indicated when the anticipated outcome is cure
-HTN, arhtralgias
-monitor: H/H TSAT, serum ferritin, BP
-do not shake

26
Q

hemolytic anemia

A

drug induced, sickle cell, or G6PD deficiency

27
Q

drugs that cause hemolytic anemia

A

cephalosporins, dapsone, isoniazid, levodopa, methyldopa, methylene blue, nitrofurantoin, pegloticase, penicillins, primaquine, quinidine, quinine, rasburicase, rifampin, sulfonamides

28
Q

immunizations in sickle cell disease: routine childhood series

A

Hib and PCV13

29
Q

immunizations in sickle cell disease: additional vaccines for functional asplenia

A

meningococcal conjugate series + booster
meningococcal serogroup B
pneumococcal vaccines: PCV20 x1 or PCV15 x1 followed by PPSV23 > 8 weeks later

30
Q

Infections: sepsis and meningitis

A

S.pneumoniae, H. influenza, N. menigitidis
-utilize prophylactic penicillin

31
Q

disease-modifying drug in sickle cell disease

A

hydroxyurea

32
Q

Hydroxyurea (Draxia, Hydrea, Siklos)

A

-myelosuppression, fetal toxicity, avoid live vaccinations
-CBC w/diff every 2-4 weeks during initiation and titration
-contraception required
-folic acid supplementation
-hazardous (wear gloves and wash hands)

33
Q

L-glutamine (Endari)

A

reduce complications of SCD

34
Q

Voxelotor (Oxbryta)

A

inhibiting HgbS polymerization

35
Q

Crizanlizumab (Adakveo)

A

reduce frequency VOC in SCD